Plain-English translation of NCT07659704 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Lupus Erythematosus, Systemic research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
Brazil
Phase
Safety & dosing / Early efficacy
Sponsor
University of Sao Paulo
Collaborators
Regional Blood Center of Ribeirao Preto
Enrollment target
~16 participants
Started
October 2026
Primary completion
October 2027
Age range
18 Years – 50 Years
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Diego V. Clé, MD, MBA, PhD
University of Sao Paulo
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.